Assiut university faculty of medicine
Asyut, Egypt
NCT Number: NCT04608006
Over an 8-year period, 124 twin pregnancies at gestational age ≥32 weeks with both twins presenting as a vertex and eligible for vaginal delivery were reviewed. Excluded were patients with the following intrapartum factors which may affect mode of delivery of second twin: 1. Presentation of the 2nd twin: breech or other than vertex; 2. Monochorionic twins; 3. Induction of labour; 4. difference in foetal weight between twin B and twin A ≥25%. The chi-square statistic was used to compare differences in the incidence of retained second twin between the groups.
Looking for future studies?
Notify Me16 year–45 year
Female
Observational
Asyut, Egypt
The investigators conducted this prospective study in women with twins pregnancy planned for trial of vaginal delivery and gave birth between January 2014 and December 2019, in the Department of obstetrics and Gynaecology of the Sabah Maternity Hospital, Sabah Specialized Area, Kuwait. The Sabah Maternity Hospital is a tertiary care hospital for the country of Kuwait with approximately 12500 deliveries per year. The study protocol was approved by the Ethics Committee.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
.gestational age of 32 weeks, determined by an early ultrasound performed in the second trimester or certain last menstrual period; (2) both twins viable; (3) eligibility for vaginal delivery as defined by twin A being cephalic; and (4) no previous cesarean section.
Exclusion criteria
Initial epidural bolus of 10 ml Bupivacaine 0.125% plus 50 mcg Fentanyl, followed by continuous infusion pf Bupivacaine 0.0625%™ plus 1mcg/dl Fentanyl
Other names: Epidural Catheter insertion
Time frame: 24 hours
Vaginal or C-Section
Time frame: 24 hours
C-Section or C-Section
Abdelrady S Ibrahim, MD
Other
Epidural Analgesia and Delivery of Second Twin: Prospective Observational Study
Acronym: Epidural
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04521556
Agnosia, Analgesia
Split, Croatia
View Trial DetailsNCT04587505
Agnosia, Analgesia
Split, Croatia
View Trial DetailsNCT04028284
Agnosia, Anesthesia
Toronto, Canada
View Trial DetailsNCT06790745
Brain Diseases, Central Nervous System Diseases
Tanta, El-Gharbia, Egypt
View Trial Details